Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From community to policy: a frontline model for dementia assessment and brain health.

Frontiers in dementia·2026
Same author

Ceramide-rich extracellular vesicles as pathogenic biomarkers in traumatic brain injury.

Acta neuropathologica communications·2026
Same author

Trafficking of protein kinases to mitochondria: Implications for ischemic stroke.

Experimental gerontology·2026
Same author

Spatial, temporal and sex specific mitochondrial dynamic changes in severe controlled cortical impact mouse model of traumatic brain injury.

bioRxiv : the preprint server for biology·2026
Same author

Ceramide-rich extracellular vesicles as pathogenic biomarkers in traumatic brain injury.

bioRxiv : the preprint server for biology·2026
Same author

Ketogenic drug tricaprilin (CER-0001) for the treatment of refractory infantile epileptic spasms: a phase 1/2a study.

Frontiers in pediatrics·2026
Same journal

IGFBP3 and UBE2C are associated with protein modification pathways and serve as prognostic markers in glioma.

Brain research·2026
Same journal

Targeting neurodevelopmental miR132-3p promotes neuroprotection and axon regeneration after optic nerve injury in mice.

Brain research·2026
Same journal

Variability in acoustic startle response and prepulse inhibition across adulthood in Fragile X messenger ribonucleoprotein 1 knockout mice.

Brain research·2026
Same journal

Transcriptome-guided modeling reveals insulin-related metabolic dysfunction in SCA3 mouse cerebellum.

Brain research·2026
Same journal

Intranasal stromal cell-derived factor-1α mitigates parkinsonian deficits via dual modulation of neuroinflammation and gut microbiota in MPTP-induced models.

Brain research·2026
Same journal

Emotions, the amygdala, and the right hemisphere.

Brain research·2026
See all related articles

Related Experiment Video

Updated: Jul 4, 2026

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
12:32

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds

Published on: January 23, 2018

Induction of ketosis may improve mitochondrial function and decrease steady-state amyloid-beta precursor protein

Christa M Studzinski1, William A MacKay, Tina L Beckett

  • 1Department of Pharmacology, University of Toronto, Canada.

Brain Research
|June 28, 2008
PubMed
Summary
This summary is machine-generated.

Medium chain triglycerides (MCTs) improved brain energy metabolism and reduced amyloid precursor protein (APP) levels in aged dogs, offering a potential therapeutic strategy for Alzheimer's disease (AD) by providing an alternative energy source for neurons.

More Related Videos

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models
08:48

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models

Published on: June 30, 2023

Related Experiment Videos

Last Updated: Jul 4, 2026

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
12:32

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds

Published on: January 23, 2018

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models
08:48

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models

Published on: June 30, 2023

Area of Science:

  • Neuroscience
  • Metabolic Disorders
  • Neurodegenerative Diseases

Background:

  • Alzheimer's disease (AD) is characterized by early, progressive declines in cerebral glucose metabolism, presenting a therapeutic target.
  • Medium chain triglycerides (MCTs) can be converted to ketone bodies, offering a potential alternative energy source for neurons with impaired glucose metabolism.

Purpose of the Study:

  • To investigate the short-term effects of MCT administration on brain energy metabolism and amyloid pathology in aged dogs, a natural model of amyloidosis.

Main Methods:

  • Aged dogs were administered 2 g/kg/day of MCTs for 2 months.
  • Assays for mitochondrial function, oxidative damage, amyloid precursor protein (APP) processing, and beta-site APP cleaving enzyme (BACE1) were performed on brain tissue.

Main Results:

  • MCT administration significantly improved mitochondrial function, indicated by increased respiration rates, particularly in the parietal lobe.
  • A decrease in oxidative damage was observed within the mitochondrial fraction.
  • Steady-state APP levels were reduced in the parietal lobe, with a trend towards decreased total amyloid-beta (Abeta) levels.

Conclusions:

  • Short-term MCT administration enhances brain energy metabolism and reduces APP levels in aged dogs.
  • MCTs show promise as a therapeutic intervention for conditions like Alzheimer's disease by addressing metabolic dysfunction.